Hypertension--drug management.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007217:Indoramin / Q000627:therapeutic use; D007741:Labetalol / Q000627:therapeutic use; D008914:Minoxidil / Q000627:therapeutic use; D009543:Nifedipine / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D013565:Sympatholytics; D014665:Vasodilator Agents; D007217:Indoramin; D009599:Nitroprusside; D008914:Minoxidil; D002216:Captopril; D014700:Verapamil; D009543:Nifedipine; D003981:Diazoxide; D007741:Labetalol; D011224:Prazosin